I-Mab Biopharma is a biotech company focused on the development of biologics in the therapeutic areas of immuno-oncology and autoimmune diseases. Its research and development capabilities encompass discovery, translational medicine, chemistry, manufacturing and controls (CMC) for biologics, pre-clinical development and clinical development, as well as business development functions. I-Mab Biopharma's pipeline of clinical and pre-clinical stage drug candidates is driven by the Fast-to-PoC (Proof-of-Concept) and Fast-to-Market development strategies through internal R&D capabilities and global partnerships.
Net income (FY, 2019)
EBIT (FY, 2019)
Market capitalization (3-Jun-2020)
Closing stock price (3-Jun-2020)
|Company Name||Date||Deal Size|
|I-Mab Biopharma Hong Kong Limited|
|I-Mab Biopharma (Shanghai) Co., Ltd.|
|I-Mab Biopharma US Ltd.|
|I-Mab Bio-tech (Tianjin) Co., Ltd.|
When was I-Mab Biopharma founded?
I-Mab Biopharma was founded in 2016.
Who are I-Mab Biopharma key executives?
I-Mab Biopharma's key executives are Jingwu Zang, Joan Huaqiong Shen and Zheru Zhang.
How many employees does I-Mab Biopharma have?
I-Mab Biopharma has 176 employees.
What is I-Mab Biopharma revenue?
Latest I-Mab Biopharma annual revenue is ¥30 m.
What is I-Mab Biopharma revenue per employee?
Latest I-Mab Biopharma revenue per employee is ¥170.5 k.
Who are I-Mab Biopharma competitors?
Competitors of I-Mab Biopharma include ProtoKinetix, Cord Blood America and Magenta Therapeutics.
Where is I-Mab Biopharma headquarters?
I-Mab Biopharma headquarters is located at 88 Shangke Rd, Pudong Xinqu, Shanghai.
Where are I-Mab Biopharma offices?
I-Mab Biopharma has offices in Shanghai, Beijing and Gaithersburg.
How many offices does I-Mab Biopharma have?
I-Mab Biopharma has 3 offices.
Receive alerts for 300+ data fields across thousands of companies